High effectiveness of efavirenz-based highly active antiretroviral therapy in HIV-1-infected patients with fewer than 100 CD4 cells/μl and opportunistic diseases: the EfaVIP Study (Efavirenz in Very Immunosuppressed Patients)
2002 ◽
Vol 16
(11)
◽
pp. 1554-1556
◽
Jose R. Arribas
◽
Federico Pulido
◽
Jose M. Miró
◽
María A. Costa
◽
Juan González
◽
...